TABLE 8.
Candidate | Type of vaccine | Target(s) | Reference(s) |
---|---|---|---|
gB | Recombinant protein | gB | 168 |
MVA Triplex | Vector (MVA) | pp65, IE1-exon 4, and IE2-exon 5 | 174, 279 |
HB-101 | Vector (LCMV) | gB and pp65 | 175 |
ASP0113 | DNA | gB and pp65 | 132, 169 |
PepVax | Chimeric peptide | pp65 | 171, 172 |
ALVAC-pp65 | Vector (canarypox virus) | pp65 | 280, 281 |
Towne | Attenuated strain | Whole virus | 282 |